48 related articles for article (PubMed ID: 26467564)
21. A single replacement of histidine to arginine in EGFR-lytic hybrid peptide demonstrates the improved anticancer activity.
Tada N; Horibe T; Haramoto M; Ohara K; Kohno M; Kawakami K
Biochem Biophys Res Commun; 2011 Apr; 407(2):383-8. PubMed ID: 21396910
[TBL] [Abstract][Full Text] [Related]
22. A novel hybrid peptide targeting EGFR-expressing cancers.
Kohno M; Horibe T; Haramoto M; Yano Y; Ohara K; Nakajima O; Matsuzaki K; Kawakami K
Eur J Cancer; 2011 Mar; 47(5):773-83. PubMed ID: 21112771
[TBL] [Abstract][Full Text] [Related]
23. Serological diagnostic factors for liver metastasis in patients with colorectal cancer.
Wu XZ; Ma F; Wang XL
World J Gastroenterol; 2010 Aug; 16(32):4084-8. PubMed ID: 20731024
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies in the treatment of metastatic colorectal cancer: a review.
Tol J; Punt CJ
Clin Ther; 2010 Mar; 32(3):437-53. PubMed ID: 20399983
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic cancer therapy with a novel pump for controlled drug release.
Haramoto M; Kohno M; Nakajima O; Horibe T; Kiyohara M; Fukazawa H; Togawa T; Kawakami K
Oncol Rep; 2010 Feb; 23(2):365-70. PubMed ID: 20043096
[TBL] [Abstract][Full Text] [Related]
26. Experimental antibody therapy of liver metastases reveals functional redundancy between Fc gammaRI and Fc gammaRIV.
Otten MA; van der Bij GJ; Verbeek SJ; Nimmerjahn F; Ravetch JV; Beelen RH; van de Winkel JG; van Egmond M
J Immunol; 2008 Nov; 181(10):6829-36. PubMed ID: 18981101
[TBL] [Abstract][Full Text] [Related]
27. K-ras mutations and benefit from cetuximab in advanced colorectal cancer.
Karapetis CS; Khambata-Ford S; Jonker DJ; O'Callaghan CJ; Tu D; Tebbutt NC; Simes RJ; Chalchal H; Shapiro JD; Robitaille S; Price TJ; Shepherd L; Au HJ; Langer C; Moore MJ; Zalcberg JR
N Engl J Med; 2008 Oct; 359(17):1757-65. PubMed ID: 18946061
[TBL] [Abstract][Full Text] [Related]
28. Peptide-based probes for cancer imaging.
Reubi JC; Maecke HR
J Nucl Med; 2008 Nov; 49(11):1735-8. PubMed ID: 18927341
[TBL] [Abstract][Full Text] [Related]
29. Characterization of HCT116 human colon cancer cells in an orthotopic model.
Rajput A; Dominguez San Martin I; Rose R; Beko A; Levea C; Sharratt E; Mazurchuk R; Hoffman RM; Brattain MG; Wang J
J Surg Res; 2008 Jun; 147(2):276-81. PubMed ID: 17961596
[TBL] [Abstract][Full Text] [Related]
30. Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells.
Ishizu K; Sunose N; Yamazaki K; Tsuruo T; Sadahiro S; Makuuchi H; Yamori T
Biol Pharm Bull; 2007 Sep; 30(9):1779-83. PubMed ID: 17827739
[TBL] [Abstract][Full Text] [Related]
31. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/gammacnull (NOG) mice.
Suemizu H; Monnai M; Ohnishi Y; Ito M; Tamaoki N; Nakamura M
Int J Oncol; 2007 Oct; 31(4):741-51. PubMed ID: 17786304
[TBL] [Abstract][Full Text] [Related]
32. In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases.
Bouvet M; Tsuji K; Yang M; Jiang P; Moossa AR; Hoffman RM
Cancer Res; 2006 Dec; 66(23):11293-7. PubMed ID: 17145875
[TBL] [Abstract][Full Text] [Related]
33. In vivo and in vitro antitumor activity of oxaliplatin in combination with cetuximab in human colorectal tumor cell lines expressing different level of EGFR.
Balin-Gauthier D; Delord JP; Rochaix P; Mallard V; Thomas F; Hennebelle I; Bugat R; Canal P; Allal C
Cancer Chemother Pharmacol; 2006 Jun; 57(6):709-18. PubMed ID: 16320055
[TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor receptor (EGFR)-related protein inhibits multiple members of the EGFR family in colon and breast cancer cells.
Xu H; Yu Y; Marciniak D; Rishi AK; Sarkar FH; Kucuk O; Majumdar AP
Mol Cancer Ther; 2005 Mar; 4(3):435-42. PubMed ID: 15767552
[TBL] [Abstract][Full Text] [Related]
35. Epidermal growth factor receptor as a therapeutic target for the treatment of colorectal cancer.
Amador ML; Hidalgo M
Clin Colorectal Cancer; 2004 May; 4(1):51-62. PubMed ID: 15207021
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and prevention of colorectal cancer.
Hawk ET; Limburg PJ; Viner JL
Surg Clin North Am; 2002 Oct; 82(5):905-41. PubMed ID: 12507200
[TBL] [Abstract][Full Text] [Related]
37. Sensitive detection of K-ras mutations augments diagnosis of colorectal cancer metastases in the liver.
Schimanski CC; Linnemann U; Berger MR
Cancer Res; 1999 Oct; 59(20):5169-75. PubMed ID: 10537293
[TBL] [Abstract][Full Text] [Related]
38. Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection.
An Z; Jiang P; Wang X; Moossa AR; Hoffman RM
Clin Exp Metastasis; 1999 May; 17(3):265-70. PubMed ID: 10432012
[TBL] [Abstract][Full Text] [Related]
39. Colorectal cancer: metastatic patterns and prognosis.
Patanaphan V; Salazar OM
South Med J; 1993 Jan; 86(1):38-41. PubMed ID: 8420014
[TBL] [Abstract][Full Text] [Related]
40. Metastatic behavior of human tumor cell lines grown in the nude mouse.
Kozlowski JM; Fidler IJ; Campbell D; Xu ZL; Kaighn ME; Hart IR
Cancer Res; 1984 Aug; 44(8):3522-9. PubMed ID: 6744277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
